Use of continuous glucose monitoring in non-intensively managed type 2 diabetes: a Saudi Arabian consensus

BackgroundSaudi Arabia has one of the highest prevalences of diabetes globally, with 16.4% of the population living with type 2 diabetes (T2D). While continuous glucose monitoring (CGM) is widely used for patients with type 1 diabetes, evidence suggests its benefits can extend to patients with T2D....

Descripció completa

Dades bibliogràfiques

Autors principals:	Mohammed Almehthel, Abdulghani Al-Saeed, Fahad Al-Sabaan, Faisal Al-Malky, Hawazen Zarif, Lamya Al-Zubaidi, Mohammed E. Al-Sofiani, Omar Abdulaal, Reem Al Argan, Saud Al Sifri, Turki Al-Harbi, Raed Aldahash
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-01-01
Col·lecció:	Frontiers in Endocrinology
Matèries:	continuous glucose monitoring non-intensive oral antidiabetics Saudi Arabia type 2 diabetes
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1738398/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!